Literature DB >> 2043938

Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue.

J Newcombe1, C P Hawkins, C L Henderson, H A Patel, M N Woodroofe, G M Hayes, M L Cuzner, D MacManus, E P du Boulay, W I McDonald.   

Abstract

Postmortem unfixed whole brains from 17 multiple sclerosis and 6 control cases were examined by magnetic resonance imaging (MRI) using a T2-weighted spin echo sequence and histology to determine the relationship between areas of abnormal MRI signal and underlying pathological change. In group 1, small MRI lesions and correspondingly small plaques, most of which were chronic, were detected histologically in 5 brains. In 4 brains there were more extensive areas of both abnormal signal and histological plaques which were more often active (group 2). However, in a further 5 brains extensive MRI abnormalities were observed when only small periventricular plaques were present histologically (group 3). Lesions in the hindbrain and cerebral grey matter were infrequently observed by MRI. The extensive MRI abnormalities seen in areas in which only small histological plaques were found may be the result of vascular permeability changes in the normal-appearing white matter surrounding plaques.

Entities:  

Mesh:

Year:  1991        PMID: 2043938     DOI: 10.1093/brain/114.2.1013

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  29 in total

1.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

Review 2.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

3.  Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis.

Authors:  M D Boggild; R Williams; N Haq; C P Hawkins
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

Review 4.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

Review 5.  Immune control of the brain.

Authors:  M Bradl
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.

Authors:  Y Ge; R I Grossman; J K Udupa; J S Babb; D L Kolson; J C McGowan
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

7.  Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index.

Authors:  L E Hughes; S Bonell; R S Natt; C Wilson; H Tiwana; A Ebringer; P Cunningham; V Chamoun; E J Thompson; J Croker; J Vowles
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

8.  Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2011-08-24       Impact factor: 4.849

9.  Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

Authors:  M Filippi; G J Barker; M A Horsfield; P R Sacares; D G MacManus; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

10.  Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation.

Authors:  Robert J Dawe; David A Bennett; Julie A Schneider; Sunil K Vasireddi; Konstantinos Arfanakis
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.